A quantitative PCR assay for SV40 neutralization adaptable for high-throughput applications

被引:10
作者
Murata, Haruhiko [1 ]
Teferedegne, Belete [1 ]
Lewis, Andrew M., Jr. [1 ]
Peden, Keith [2 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Lab DNA Viruses, Div Viral Prod, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Lab Retrovirus Res, Div Viral Prod, Bethesda, MD 20892 USA
关键词
SV40; Polyomavirus; Neutralization; Antibody; Quantitative PCR; SYBR Green; CAPSID PROTEIN; REAL-TIME; BK VIRUS; HEMAGGLUTINATION INHIBITION; PARVOVIRUS B19; HUMAN SERA; POLYOMAVIRUS; IDENTIFICATION; ANTIBODIES; REACTIVITY;
D O I
10.1016/j.jviromet.2009.08.012
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A neutralization assay incorporating a quantitative SYBR Green PCR endpoint has been developed for SV40. The present study demonstrates that crude virus samples can serve as suitable amplification templates for quantitative PCR without the need for nucleic acid extraction. The denaturation temperature of thermocycling appears to be sufficient to release the encapsidated viral genome and allow its availability as a PCR template. Issues arising from inhibitors of PCR present in crude virus samples can be circumvented easily by a 100-fold dilution step. Using a streamlined procedure that eliminates sample nucleic acid extraction (a hitherto rate-limiting step that diminishes throughput substantially), quantitative PCR was applied in order to assess: (1) the replication kinetics of SV40 and (2) the inhibition of SV40 productive infection by neutralizing antibodies. A similar high-throughput approach might be feasible for related polyomaviruses (e.g., BKV and JCV) as well as for other families of viruses. Published by Elsevier B.V.
引用
收藏
页码:236 / 244
页数:9
相关论文
共 34 条
  • [1] Identification of a third human polyomavirus
    Allander, Tobias
    Andreasson, Kalle
    Gupta, Shawon
    Bjerkner, Annelie
    Bogdanovic, Gordana
    Persson, Mats A. A.
    Dalianis, Tina
    Ramqvist, Torbjorn
    Andersson, Bjorn
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (08) : 4130 - 4136
  • [2] BABE LM, 1989, J BIOL CHEM, V264, P2665
  • [3] Progressive multifocal leukoencephalopathy
    Berger, Joseph R.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2007, 7 (06) : 461 - 469
  • [4] B-LYMPHOTROPIC PAPOVAVIRUS AND POSSIBILITY OF INFECTIONS IN HUMANS
    BRADE, L
    MULLERLANTZSCH, N
    HAUSEN, HZ
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1980, 6 (04) : 301 - 308
  • [5] Buck CB, 2005, METH MOLEC MED, V119, P445
  • [6] Lack of serologic evidence for prevalent simian virus 40 infection in humans
    Carter, JJ
    Madeleine, MM
    Wipf, GC
    Garcea, RL
    Pipkin, PA
    Minor, PD
    Galloway, DA
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (20): : 1522 - 1530
  • [7] First identification and molecular characterization of lymphotropic polyomavirus in peripheral blood from patients with leukoencephalopathies
    Delbue, Serena
    Tremolada, Sara
    Branchetti, Emanuela
    Elia, Francesca
    Gualco, Elisa
    Marchioni, Enrico
    Maserati, Renato
    Ferrante, Pasquale
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (07) : 2461 - 2462
  • [8] Polyomavirus BK infection in blood and marrow transplant recipients
    Dropulic, L. K.
    Jones, R. J.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 (01) : 11 - 18
  • [9] Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586
  • [10] DETECTION OF BK VIRUS-ANTIBODIES MEASURED BY ENZYME-LINKED IMMUNOSORBENT-ASSAY (ELISA) AND 2 HEMAGGLUTINATION INHIBITION METHODS - A COMPARATIVE-STUDY
    FLAEGSTAD, T
    TRAAVIK, T
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1985, 16 (04) : 351 - 356